Composite Helper Genes for High-Yield AAV Vector Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing adeno-associated virus (AAV) vectors, such as those using adenovirus as a helper virus, face challenges in achieving high yields.

Innovation Solution

Incorporation of specific virus-derived genes, including adenovirus and herpesvirus-derived genes associated with replication, into producer cells to enhance AAV vector production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If adenovirus is used as a helper virus to produce AAV vectors, then AAV vector production can be achieved, but the yield of AAV vectors is insufficient

Engineering Contradiction:
ImproveAAV vector yieldVSAvoidAAV vector quantity
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent combines adenovirus-derived helper genes (E1A, E1B, E2, E4, VA) with herpesvirus-derived replication genes (UL5, UL8, UL29, UL30, UL42, UL52) into a composite helper system. This merging of two different viral gene systems creates synergistic effects that significantly enhance AAV vector yield beyond what either system can achieve alone.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite genetic system by integrating multiple virus-derived genes into the producer cells. This composite approach combines the helper functions of adenovirus with the replication capabilities of herpesvirus, resulting in a enhanced production system that overcomes the yield limitations of using adenovirus alone.

Inventive Principle:
Principle #40Composite materials

2Productivity

If traditional adenovirus helper system is used, then AAV vector production is possible, but production efficiency is low

Engineering Contradiction:
Improveproduction efficiencyVSAvoidvector yield
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent fundamentally changes the genetic parameters of the helper system by introducing herpesvirus-derived replication genes (DNA polymerase, helicase, primase, ssDNA-binding protein) to the traditional adenovirus helper system. This parameter change in the molecular composition of the helper system dramatically improves production efficiency and vector yield.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The combined helper system performs multiple functions simultaneously: the adenovirus-derived genes provide early infection and transcription functions, while the herpesvirus-derived genes provide DNA replication functions. This multi-functional helper system resolves the productivity-quantity contradiction by coordinating diverse viral functions for enhanced AAV production.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP4660308A1Helper gene
Publication Date: 2025.12.10 SYNPLOGEN CO LTD
  • EP4660308A1 patent drawingFigure 1
  • EP4660308A1 patent drawingFigure 2~3
  • EP4660308A1 patent drawingFigure 4A~4B

AI summary

The present disclosure provides a virus-derived gene that can be used for producing a novel virus-derived construct. More particularly, the virus-derived gene of the present disclosure includes a combination of an adenovirus-derived gene and a herpesvirus-derived gene. In one embodiment, the herpesvirus-derived gene is a gene associated with replication of a gene. In one embodiment, the herpesvirus-derived gene encodes a protein selected from a helicase, a primase, an ssDNA-binding protein (DBP), a DNA polymerase, and a DNA replication protein. In one embodiment, the herpesvirus-derived gene encodes a protein selected from an ssDNA-binding protein (DBP) and a DNA polymerase. In one embodiment, the herpesvirus-derived gene includes a gene selected from UL44, UL54, and UL57.